Top Sell
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs ▲ | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Trevena Inc. | 3 | 18 | 1 | 4 | 0,21 € | 4,60 € | 2131,80 % |
| Sage Therapeutics Inc. | 7 | 4 | 2 | 1 | 9,99 € | 26,21 € | 162,26 % |
| Chimerix Inc. | 3 | 1 | 0 | 0 | 0,84 € | 5,51 € | 559,64 % |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | 0,91 € | 6,49 € | 611,60 % |
| Ocuphire Pharma Inc. | 6 | 1 | 0 | 0 | 1,42 € | 18,37 € | 1189,75 % |
| T2 Biosystems Inc. | 0 | 8 | 0 | 0 | 0,16 € | - | - |
| Fate Therapeutics Inc. | 3 | 3 | 1 | 0 | 3,06 € | 7,31 € | 139,06 % |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | 0,22 € | - | - |
| Omnicell Inc. | 3 | 2 | 0 | 0 | 23,80 € | 35,45 € | 48,97 % |
| Sangamo Therapeutics Inc. | 12 | 12 | 0 | 0 | 0,35 € | 3,63 € | 944,37 % |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | 0,97 € | - | - |
| Bruker Corp. | 9 | 1 | 1 | 0 | 59,56 € | 84,02 € | 41,07 % |
| Intellia Therapeutics Inc | 17 | 1 | 4 | 0 | 20,88 € | 60,53 € | 189,92 % |
| Henry Schein Inc. | 13 | 1 | 1 | 0 | 59,86 € | 79,66 € | 33,07 % |
| Carisma Therapeutics Inc. | 0 | 1 | 0 | 1 | 1,43 € | - | - |
| Avinger Inc. | 2 | 4 | 0 | 0 | 0,34 € | 4,64 € | 1272,63 % |
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | 38,69 € | 70,67 € | 82,64 % |
| InVivo Therapeutics Holdings | 1 | 15 | 0 | 0 | 0,34 € | 1,60 € | 376,19 % |
| Pacific Biosciences of California Inc. | 10 | 5 | 1 | 0 | 1,27 € | 10,05 € | 688,49 % |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | 0,34 € | 21,06 € | 6072,33 % |
| Nevro Corp. | 3 | 2 | 0 | 0 | 7,65 € | 25,71 € | 236,14 % |
| Rocket Pharmaceuticals Inc | 2 | 1 | 1 | 0 | ? | 32,00 € | 59,20 % |
| Teladoc Health Inc | 12 | 1 | 1 | 0 | 9,14 € | 23,12 € | 153,01 % |
| Cytomx Therapeutics Inc | 2 | 1 | 1 | 0 | 1,14 € | 50,00 € | 4270,63 % |
| Integra LifeSciences Holdings Corp | 3 | 3 | 0 | 0 | 26,80 € | 34,68 € | 29,40 % |